Literature DB >> 26966524

Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices.

Nobuo Waguri1, Akihiko Osaki1, Shunzo Ikarashi1, Masahiro Ogawa1, Naosuke Kuraoka1, Kohei Ogawa1, Munehiro Sato1, Tsuneo Aiba1, Osamu Yoneyama1, Koichi Furukawa1, Kazuhito Sugimura1, Kentarou Igarashi1.   

Abstract

BACKGROUND: We previously reported the techniques and usefulness of simultaneous combined balloon-occluded retrograde transvenous obliteration (B-RTO) and partial splenic embolization (PSE), based on the hypothesis that concomitant PSE can diminish the increase in portal venous pressure after B-RTO.
OBJECTIVE: After experiencing more cases and performing longer-term follow-up, we re-evaluated the efficacy of simultaneous combined B-RTO and PSE for gastric fundal varices (GVs).
METHODS: We performed B-RTO in 36 consecutive patients treated for GVs from 2005 to 2013. Twenty-three patients underwent simultaneous combined B-RTO and PSE (Group 1) and 13 underwent B-RTO monotherapy (Group 2). The outcomes were retrospectively evaluated.
RESULTS: There were no significant differences in baseline characteristics between the two groups except that the splenic volumes were larger in Group 1 than 2. B-RTO was technically successful in 21 of 23 patients (91.3%) in Group 1 and in 12 of 13 patients (92.3%) in Group 2. In all patients with ruptured GVs (six in Group 1 and five in Group 2), complete hemostasis was obtained by B-RTO. Exacerbation of esophageal varices was significantly less frequent in Group 1 than 2 (p = 0.0017).
CONCLUSION: Concomitant PSE with B-RTO may contribute to prevention of the exacerbation of esophageal varices after B-RTO.

Entities:  

Keywords:  Gastric varices; balloon-occluded retrograde transvenous obliteration; esophageal varices; partial splenic embolization; portal hypertension

Year:  2015        PMID: 26966524      PMCID: PMC4766542          DOI: 10.1177/2050640615581966

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  34 in total

Review 1.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

Review 2.  Primary prophylaxis for variceal bleeding: are we there yet?

Authors:  Thomas D Boyer
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

3.  Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso; Yasuhiro Makino; Syunsuke Saito; Yasushi Shiratori
Journal:  Clin Gastroenterol Hepatol       Date:  2005-12       Impact factor: 11.382

Review 4.  Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage.

Authors:  Romaric Loffroy; Louis Estivalet; Violaine Cherblanc; Sylvain Favelier; Pierre Pottecher; Samia Hamza; Anne Minello; Patrick Hillon; Pierre Thouant; Pierre-Henri Lefevre; Denis Krausé; Jean-Pierre Cercueil
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

5.  Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients.

Authors:  Teruhisa Ninoi; Norifumi Nishida; Toshio Kaminou; Yukimasa Sakai; Toshiaki Kitayama; Masao Hamuro; Ryusaku Yamada; Kenji Nakamura; Tetsuo Arakawa; Yuichi Inoue
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

6.  Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.

Authors:  T Fukuda; S Hirota; K Sugimura
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

7.  Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration.

Authors:  Saher S Sabri; Nadine Abi-Jaoudeh; Warren Swee; Wael E Saad; Ulku C Turba; Stephen H Caldwell; John F Angle; Alan H Matsumoto
Journal:  J Vasc Interv Radiol       Date:  2014-01-24       Impact factor: 3.464

8.  A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.

Authors:  G-H Lo; H-L Liang; W-C Chen; M-H Chen; K-H Lai; P-I Hsu; C-K Lin; H-H Chan; H-B Pan
Journal:  Endoscopy       Date:  2007-08       Impact factor: 10.093

9.  Predictive factors of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration in patients with gastric varices.

Authors:  Mahmoud K Elsamman; Yasuhiro Fujiwara; Natsuhiko Kameda; Hirotoshi Okazaki; Tetsuya Tanigawa; Masatsugu Shiba; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Usama A Arafa; Adel A El-Sayed; Kenji Nakamura; Tetsuo Arakawa
Journal:  Am J Gastroenterol       Date:  2009-03-24       Impact factor: 10.864

10.  Management of bleeding gastric varices: a single session of histoacryl injection may be sufficient.

Authors:  Ali Khawaja; Ambreen A Sonawalla; Sana F Somani; Shahab Abid
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 2.566

View more
  1 in total

1.  Balloon-occluded retrograde transvenous obliteration for gastric varices improves hepatic functional reserve in long-term follow-up.

Authors:  Nobuo Waguri; Akihiko Osaki; Yusuke Watanabe; Tsuyoshi Matsubara; Shun Yamazaki; Hanako Yokoyama; Kiwamu Kimura; Takuya Wakabayashi; Masaki Mito; Shunta Yakubo; Rie Azumi; Junji Kohisa; Kennichi Takaku; Munehiro Sato; Kouichi Furukawa
Journal:  JGH Open       Date:  2021-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.